SEPT3 as a Potential Molecular Target of Triple-Negative Breast Cancer
Li-Hua Yang,Guo-Zhou Wang,Chao Gao
DOI: https://doi.org/10.2147/ijgm.s462541
IF: 2.145
2024-04-26
International Journal of General Medicine
Abstract:Li-Hua Yang, 1, &ast Guo-Zhou Wang, 1, &ast Chao Gao 2 1 Department of Breast Tumor Surgery, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, Hubei, People's Republic of China; 2 Department of General Practitioner, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chao Gao, Department of General Practitioner, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, Huangshi, Hubei, 435000, People's Republic of China, Email Background: The survival rate for triple-negative breast cancer (TNBC) is very low due to its advanced metastatic and aggressive nature, and there is no specific target to improve the survival rate. The expression and clinical signature of neuronal-specific septin-3 (Septin3, SEPT3) in TNBC remain undetermined. Methods: SEPT3 differential expression in TNBC was detected with the use of bioinformatic approaches based on TCGA and GEO database, which was verified with immunohistochemistry in TNBC tissues. Next, the effect of SEPT3 on survival and the association between SEPT3 expression and clinical characteristics were assessed for TNBC patients. We performed Cox analysis to evaluate whether SEPT3 is an independent predictor for TNBC patients. Results: SEPT3 was identified as a key differentially expressed gene. SEPT3 was observed to be elevated in 112 TNBC significantly. Increased expression of SEPT3 contributed to an unfavorable prognosis in patients with TNBC. Additionally, SEPT3 was associated with several factors including TNM stage, lymph node metastasis, Ki67 level and histological grade. SEPT3 was determined to be an independent risk factor for TNBC patients through Cox regression analysis. Conclusion: This study demonstrated that SEPT3 could be a potential disease marker for TNBC patients by bioinformatics analysis and validation in clinical samples. Keywords: triple-negative breast cancer, STEP3, prognosis, biomarker As a heterogeneous disease, the absence or presence status of hormone receptors and human epidermal growth factor receptor-2 (HER2) is used to classify breast cancer subtypes. 1 Triple-negative breast cancer (TNBC) is the one that lacks detectable expression of three index: estrogen and progesterone receptors (ER, PR) and HER2. Given these properties, endocrine therapy and targeted therapy have poor efficacy for patients with TNBC. 2 Recently, the clinical treatment for TNBC is mainly chemotherapy combining paclitaxel and platinum with little benefit. 3 Therefore, the poor prognosis of TNBC patients requires identifying specific molecular targets. Septins, a highly conserved guanosine triphosphate (GTP) binding protein family, can be divided into four homology subgroups. 4 In addition to their GTPase function, septins can take part in initiating homo- or heterooligomeric complexes, which are essential for maintaining the cytoskeleton. 5 Recently, the role of septins in cancer was gradually excavated. Septin9 was found to be overexpressed in human breast cancer. 6 In colorectal cancer, Septin9 could serve as a specific blood marker. 7 Besides, Septin9 could affect cell invasion and metastasis in melanoma. 8 Cancer-associated fibroblasts (CAFs) tend to facilitate cancer invasion and angiogenesis via remodeling the tumor matrix. It has been reported that Septin2 was involved in the regulation of matrix remodeling and tumor-growth promoting mediated by CAFs. 9 A growing body of evidence demonstrated that septins play a key role in cancer. Neuron-specific septin-3 (Septin3, SEPT3), of the SEPT3 subgroup, is present in the brain and testes. In previous studies, STEP3 was identified as a component of presynaptic nerve terminals with lipid association and GTP-regulated filament assembly properties. 10 Conversely, accumulating evidence indicated that the effects of SEPT3 on neuronal development and synaptic function are negligible. 11–13 The existing body of research on SEPT3 suggested that SEPT3 correlates with autophagy in synaptic/neuronal tissue. In primary neuronal cell cultures, SEPT3 binds the autophagy-related protein LC3B, and colocalization of these proteins can be enhanced by autophagy inducers. 14 Current studies have focused on the biological effect of SEPT3 in the nervous system, while its expression pattern and prognostic value in cancer have not been reported. The expression pattern, clinical sig -Abstract Truncated-
medicine, general & internal